Home » Clinical development » D-Scape: Dengue Shock Classification and Prediction Wearable
D-Scape: Dengue Shock Classification and Prediction Wearable

Research area:

Global health

Disease:

Disease: Severe dengue haemorrhagic fever (DHF)

Intervention:

Device – Medical device

Phase:

N/A*

Funding awarded to

Imperial College London and OUCRU

Visit this trial’s project page

Related news

TYSABRI gains market approval

Read more: TYSABRI gains market approval

Keytruda receives another breakthrough designation

Read more: Keytruda receives another breakthrough designation
Melanie Lee, LifeArc CEO

LifeArc monetises Keytruda® royalty interests to fund further research and investment

Read more: LifeArc monetises Keytruda® royalty interests to fund further research and investment